NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $39,296,000 | -63.4% | 804,760 | -20.3% | 0.21% | -63.6% |
| Q1 2018 | $107,280,000 | +74.2% | 1,009,601 | -0.6% | 0.58% | +72.5% |
| Q4 2017 | $61,577,000 | +384.2% | 1,016,092 | -12.4% | 0.34% | +686.0% |
| Q3 2015 | $12,716,000 | +74.4% | 1,160,312 | +99.0% | 0.04% | +4.9% |
| Q2 2015 | $7,292,000 | +13.0% | 582,951 | -0.6% | 0.04% | +10.8% |
| Q1 2015 | $6,453,000 | – | 586,709 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |